Investors / France / Aloe Private Equity
Aloe Private Equity
Venture capital · Paris, France · Europe
Aloe Private Equity is an independent French asset management company founded in 2003 and approved by the AMF. It invests in private equity and venture capital, and also offers fiduciary services and fund structuring and management as a service.
Invests inHealthcare & Biotech
In its own wordsdeeptechhealthcarebiotechventure capitalprivate equityfund management
Your fit with Aloe Private Equity
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAloe Private Equity lists 1 checked portfolio company on its own site and is named in 1 funding round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in France.
Counts come from funding rounds that name Aloe Private Equity, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundAloe Private Equity does not state its stages on its site, so only what it does is shown.
The rounds that name Aloe Private Equity do not give a stage.
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Capital Grand Est | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Compare Aloe Private Equity head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Aloe Private Equity| Date | Company | Stage |
|---|---|---|
| 14 Oct 2025 | Round |
Round details for Aloe Private Equity
Amounts, full round histories and every co-investor in Aloe Private Equity's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
1 company checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| EVerZom develops exosome-based therapeutics for regenerative medicine | Healthcare & Biotech | Oct 2025Round | Funding round |
About this data
site last read 5 Nov 2026- Site
- aloe-group.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 14 Oct 2025
- Companies checked
- 1
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Aloe Private Equity's profile as data
Pull Aloe Private Equity's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/aloe-group.com
# also
GET /v1/firms/aloe-group.com/portfolio
GET /v1/firms/aloe-group.com/coinvestors
GET /v1/firms/aloe-group.com/news